Altria Group earnings calendar shapes consensus view, shares watched on NYSE

Altria Group has its next quarterly report firmly scheduled, and analysts have updated their estimates and ratings ahead of the date. Retail investors are watching how stable cash flows and dividend expectations feed into the current valuation of the shares.

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-26, 21:42.

Altria Group Inc (US02209S1033) has its next earnings date set on the corporate calendar, giving investors a clear time frame for the next update on U.S. cigarette and oral tobacco trends. The producer of Marlboro for the U.S. market trades on the NYSE, where income-focused investors track the stock for its high dividend payout, according to exchange data and company filings on the Altria investor relations site.

What the upcoming results will cover

Altria typically reports quarterly figures that detail shipment volumes, net revenues, and adjusted earnings per share for its smokeable products, oral tobacco products, and wine segments, as disclosed in its recent Form 10-Q filings with the SEC on the U.S. SEC EDGAR portal. The next earnings release is expected to update trends in Marlboro volumes, pricing, and the contribution from newer oral nicotine pouches.

Management also typically provides commentary on U.S. regulatory developments and the competitive situation in reduced-risk products, including the impact of FDA rules and the shift of some adult smokers toward vaping and oral nicotine formats, according to recent conference call transcripts summarized by market commentators on major financial news platforms.

How analysts approach Altria shares

Brokerage analysts on Wall Street and in Europe regularly update their recommendations and 12-month price targets for Altria, with many focusing on the sustainability of the dividend and the resilience of cash flows despite gradually declining cigarette volumes, as reflected in consensus data compiled by financial information providers. Some houses highlight Altria’s high free-cash-flow yield compared with consumer-staples peers such as British American Tobacco and Philip Morris International, which both also cater to investors seeking stable dividends in the tobacco sector.

Recent analyst notes, as reported in market commentary, indicate a mix of Buy, Hold, and occasionally Sell recommendations, with target prices typically set by applying a multiple to expected earnings per share and adjusting for regulatory risk and slower volume trends, according to broker research summaries available through major brokerage platforms and financial news services.

What the company sells in the U.S. market

Altria Group generates most of its revenue in the United States from the manufacture and sale of Marlboro-branded cigarettes and a portfolio of smokeless and oral tobacco products. The group also has exposure to oral nicotine pouches and maintains stakes in adjacent businesses such as alcoholic beverages and cannabis through minority shareholdings.

Where the stock trades today

Altria Group shares trade on the New York Stock Exchange (ticker: MO) in U.S. dollars; investors monitor the stock mainly for its dividend income profile and its role in U.S. consumer-staples portfolios.